HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052

• المؤلفون الرئيسيون: Philip J. Palumbo, Jessica M. Fogel, Sarah E. Hudelson, Ethan A. Wilson, Stephen Hart, Laura Hovind, Estelle Piwowar-Manning, Carole Wallis, Maria A. Papathanasopoulos, Mariza G. Morgado, Shanmugam Saravanan, Srikanth Tripathy, Joseph J. Eron, Joel E. Gallant, Marybeth McCauley, Theresa Gamble, Mina C. Hosseinipour, Nagalingeswaran Kumarasamy, James G. Hakim, Jose H. Pilotto, Johnstone Kumwenda, Victor Akelo, Sheela V. Godbole, Breno R. Santos, Beatriz Grinsztejn, Ravindre Panchia, Suwat Chariyalertsak, Joseph Makhema, Sharlaa Badal-Faesen, Ying Q. Chen, Myron S. Cohen, Susan H. Eshleman
• التنسيق: دورية
• منشور في: 2018
• الموضوعات: Medicine
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85049073758&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/62814
• المؤسسة: Chiang Mai University

© 2017 Wolters Kluwer Health, Inc. All rights reserved. Introduction: We evaluated HIV drug resistance in adults who received early vs. delayed antiretroviral therapy (ART) in a multinational trial [HIV Prevention Trials Network (HPTN) 052, enrollment 2005-2010]. In HPTN 052, 1763 index participants...